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Research 1 Article 
Assessment of Autoimmune Responses Associated with Asbestos Exposure 
in Libby, Montana, USA 
Jean C. Pfau, Jami J. Sentissi, Greg Weller, and Eiizabeth A. Putnam 
Center for Environmental Health Sciences, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 
Missoula, Montana, USA 
Systemic autoimmune responses are associated with certain environmental exposures, including 
crystalline particles such as silica. Positive antinuclear antibody (ANA) tests have been reported in 
small cohorts exposed to asbestos, but many questions remain regarding the prevalence, pattern, 
and significance of autoantibodies associated with asbestos exposures. The population in Libby, 
Montana, provides a unique opportunity for such a study because of both occupational and 
environmental exposures that have occurred as a result of the mining of asbestos-contaminated 
vermiculite near the community. As part of a multifaceted assessment of the impact of asbestos 
exposures on this population, this study explored the possibility of exacerbated autoimmune 
responses. Age- and sex-matched sets of 50 serum samples from Libby and Missoula, Montana 
(unexposed), were tested for ANA on HEp-2 cells using indirect immunofluorescence. Data 
included frequency of positive tests, ANA titers, staining patterns, and scored fluorescence inten- 
sity, all against known controls. Serum immunoglobulin A (IgA), rheumatoid factor, and anti- 
bodies to extractable nuclear antigen (ENA) were also tested. The Libby samples showed 
significandy higher frequency of positive ANA and ENA tests, increased mean fluorescence inten- 
sity and titers of the ANAs, and higher serum IgA, compared with Missoula samples. In the Libby 
samples, positive correlations were found between ANA titers and both lung disease severity and 
extent of exposure. The results support the hypothesis that asbestos exposure is associated with 
autoimmune responses and suggests that a relationship exists between those responses and 
asbestos-related disease processes. Key words: asbestos, ANA, environmental autoimmunity, 
immunotoxicology. Environ Health Perspect 113:25-30 (2005). doi:10.1289/ehp.7431 available 
via http://dx.doi.org/[OrAine 30 September 2004] 
Asbestos-related lung disease (ARD), including 
fibrosis, pleural plaques, and cancer, continues 
to be a serious and significant problem despite 
increasing awareness of the health hazards of 
asbestos inhalation. Although the exact mecha? 
nisms leading to the progression of these con? 
ditions have not been fully explained, there is 
evidence that some of the lung pathologies 
seen with both asbestos and silica exposures are 
immunologically mediated (Hamilton et al. 
1996; Holian et al. 1997; Perkins et al. 
1993). Silica and asbestos exposures also both 
appear to exacerbate autoimmune responses. 
Epidemiologic studies have shown strong asso? 
ciations between silica exposure and several 
autoimmune diseases, including scleroderma, 
systemic lupus erythematosus (SLE), and 
rheumatoid arthritis (RA) (Koeger et al. 1995; 
Parks et al. 1999; Powell et al. 1999; Steenland 
and Goldsmith 1995). Increased serum 
immunoglobulins, positive antinuclear anti? 
body (ANA) tests, and immune complexes 
have been reported in small cohorts of indi? 
viduals exposed to asbestos (Lange 1980; 
Nigam et al. 1993; Zerva et al. 1989), but to 
our knowledge no comprehensive study has 
been undertaken to assess the prevalence, 
specificity, and significance of autoantibodies 
associated with asbestos exposures. The popu? 
lation in Libby provides a unique research 
opportunity because of significant exposures 
that occurred as a result of the mining of 
asbestos-contaminated vermiculite near the 
community. Exposures have been documented 
not only in the miners but also in their family 
members, as well as anyone who used the ver? 
miculite or played near the mine tailings. 
Therefore, the Libby asbestos exposures were 
both occupational and environmental through? 
out the community (Peipins et al. 2003). 
In addition to the ARD in Libby, there 
have been anecdotal reports of an increased 
prevalence of systemic autoimmune disease 
(SAID), but verification of these diagnoses is 
still in progress. When the Centers for Disease 
Control and Prevention/Agency for Toxic 
Substances and Disease Registry (ATSDR) 
performed its screening in Libby during 
2000-2001, 494 (6.7%) of 7,307 screening 
participants indicated that they had been diag? 
nosed with either SLE, scleroderma, or RA 
(Larson T, personal communication). In con? 
trast, a prevalence of < 1 % for these three con? 
ditions combined would be expected based on 
pooled estimates from 43 prevalence studies 
(Jacobson et al. 1997). These data, along with 
extensive evidence of silica-associated auto? 
immunity, provided the impetus to initiate a 
multifaceted assessment of the impact of 
asbestos exposures on the population of Libby, 
Montana, including possible autoimmune 
responses. 
In this article we report on a study 
designed to assess whether there were humoral 
alterations in serum samples from an 
asbestos-exposed population (Libby samples) 
that might indicate autoimmune responses, 
providing the rationale for future full-scale 
studies. Serum samples of subjects from 
Libby and from a Montana community with 
no reported asbestos exposure were assayed 
for a variety of immune parameters, including 
ANA, immunoglobulin A (IgA), rheumatoid 
factor (RF), and antibodies to extractable 
nuclear antigens (ENA). 
Materials and Methods 
Human samples. All samples were acquired 
according to approved University of Montana 
institutional review board protocols, protect- 
ing the well-being and confidentiality of all 
subjects. Appropriate informed consent was 
obtained from all subjects, and a question? 
naire was administered regarding overall 
health, smoking status, asbestos exposure, 
age, sex, and recontact information. 
Two sample pools were obtained through 
other studies at the Center for Environmental 
Health Sciences. Subjects were recruited 
through flyers and ads in Missoula, Montana, 
for a study of immune function (E. Putnam), 
and serum samples were collected at the same 
time for convenience. Missoula is similar to 
Libby in that it is located in a mountain valley 
subject to similar climatic conditions, includ? 
ing winter inversions, dry summers, and expo? 
sure to smoke from fall forest fires. Because 
prevailing winds in Missoula are from the west 
and Libby is well to the north, there would be 
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no transfer of asbestos from the Libby airshed 
to the Missoula airshed. Therefore, on a rela? 
tive basis, although one cannot exclude the 
possibility that there could have been some 
minimal asbestos exposure by the Missoula 
population, it is an acceptable reference popu? 
lation for the Libby subjects who were defi- 
nitely exposed to asbestos. For this study, we 
selected 50 samples from subjects with no 
reported asbestos exposure from the Missoula 
pool, excluding any who had lived or worked 
in Libby. Concurrently, subjects were being 
recruited from Libby, Montana, for a genetic 
study of ARD susceptibility (E. Putnam), and 
the samples were drawn at the Center for 
Asbestos Related Diseases Clinic in Libby 
when subjects came for screening or responded 
to subject recruitment advertisements. From 
this pool, 50 Libby subjects were selected that 
were matched to the 50 Missoula subjects to 
give similar mean age and sex ratios for the two 
subject sets. Permission was obtained to 
acquire information about prescription drug 
use and ARD status from medical records, and 
these data were inserted into a coded database. 
Both communities from which subjects 
were drawn are fairly homogeneous in terms of 
ethnicity; most residents are of northern 
European descent, with 94.7% white in 
Lincoln County (Libby) and 93.6% white in 
Missoula County (Missoula) according to 
Montana census data (U.S. Census Bureau 
2004). The mean age for both sample sets was 
55 years (Missoula, 54.8 ? 2.5 years; Libby, 
55.0 ?2.1 years), and the male:female ratio 
was 25:25 for both sets. An exclusion criterion 
was the use of medications strongly associated 
with drug-induced autoimmunity (Fritzler 
1994). The presence of diagnosed autoim? 
mune disease did not exclude individuals from 
either sample set but was noted on intake. 
None of the Missoula subjects recruited had 
diagnosed SAID. Of the Libby subjects 
recruited initially for the genetics study, the per? 
centage with diagnosed SAID was 5.9%, and in 
the final Libby sample set of 50, there were two 
with SLE, 1 with multiple sclerosis, and 1 with 
RA. Because the individual with RA also had 
SLE, this means that three people in 50 had 
SAID (6%). These values are consistent with 
the ATSDR screening data for this community 
(Larson T, personal communication). 
The lung diseases in this community have 
been previously described (Peipins et al. 
2003) and include primarily pleural abnor? 
malities (17.8%) and interstitial abnormalities 
(< 1%). In our Libby sample set, 12 (24%) 
had no reported abnormalities, 27 (54%) had 
pleural abnormalities, 8 (16%) had interstitial 
abnormalities, and 3 (6%) had a combination 
of pleural and interstitial abnormalities. 
Sample and data collection. The blood 
samples were collected, and serum samples 
were obtained and frozen by standardized 
clinical methods to prevent differences due to 
handling. The samples were blinded with 
only sex and age noted, and stored at -80?C 
until assayed. After testing, coded informa? 
tion regarding disease status and exposure was 
obtained from the questionnaire and ATSDR 
screening data (ATSDR 2002). 
ARD and asbestos exposure rankings. 
ARD status, based on data recorded in the 
database primarily as a result of the ATSDR 
screenings, was ranked on a scale of 0-3, as 
described in Table 1. The rankings were 
intentionally simplified, based on radiographic 
evidence of single versus extensive plaques or 
interstitial abnormalities, as well as spirometry 
evidence of functional deficits. For example, a 
subject with a single pleural plaque and no 
functional deficit would be scored at 1, 
whereas a subject with bilateral plaques and 
effects on spirometry was scored at 3. To fur? 
ther break down the sample sets by disease 
types would have made the subsets too small 
for statistical analysis. Exposure status was 
ranked on a scale of 0-4, as described in 
Table 2. These scores were also simplified in 
order to focus on duration of exposure and the 
existence of occupational and/or environmen? 
tal exposure to asbestos. The rankings of the 
Libby subjects were performed independently 
by two of the researchers (J.C.P. and E.A.P.). 
Autoantibody testing. A clinical test for 
nuclear antigens (ANA assay), used to screen 
for antibodies commonly seen in SAID, was 
performed at a screening dilution of the sera. 
All serum samples were diluted 1:40 in phos? 
phate-buffered saline (PBS) and tested by 
indirect immunofluorescence (IIF) on a single 
lot of commercially prepared and fixed HEp-2 
cells (ImmunoConcepts Inc, Sacramento, 
CA), according to manufacturer's instruc? 
tions. The staining pattern and relative fluo? 
rescence intensity were compared with known 
positive and negative controls using a Zeiss 
fluorescence microscope with 40x objective 
and recorded as positive (1+ to 4+) or nega? 
tive (0). The staining pattern was also noted 
and recorded. The same microscope and set? 
tings were used for all samples, and the slides 
were read by two independent readers. 
Samples showing homogeneous staining pat? 
terns were reevaluated using the Crithidia 
luciliae substrate (ImmunoConcepts), which 
specifically detects antibodies to double- 
stranded DNA (dsDNA), and by enzyme- 
linked immunosorbent assay (ELISA) to 
detect antibodies to chromatin (INOVA 
Diagnostics, San Diego, CA), both according 
to the manufacturers' instructions. Samples 
with positive ANAs were also evaluated using 
a modified ANA test to determine whether 
any of the anti-ANA antibodies were of the 
IgA isotype. The samples were tested on 
HEp-2 slides as above, but instead of the anti- 
human IgG fluorescein isothiocyanate (FITC) 
conjugate included with the slides, we used 
goat anti-human IgA FITC conjugate 
(Southern Biotech, Birmingham, AL). The 
slides were read as described above. 
IgA ELISA. For detection of serum IgA, 
the mucosal antibody isotype, 96-well polysorb 
plates (Nunc, Rochester, NY) were coated with 
1 ug/mL of anti-human kappa light chain 
(Southern Biotech) in carbonate coating buffer 
overnight at 4?C. Wells were then blocked 
with PBS containing 1% bovine serum albu- 
min (BSA) for 1 hr. Subject samples were 
diluted 1:4,000, 1:8,000, and 1:16,000 in efflu? 
ent buffer (PBS, 1% BSA, 0.1% Tween-20). 
Samples, standards, and blanks were added to 
wells to give 100 uL/well. After 1 hr, plates 
were washed with three changes of PBS con? 
taining 0.1% Tween-20. The detection anti? 
body [goat anti-human IgA alpha chain 
coupled to horseradish peroxidase (HRP); 
Caltag, Burlingame, CA] was added and the 
plates were incubated for 1 hr at room temper? 
ature. The plates were washed again and devel? 
oped using HRP-tetramethylbenzidine (TMB) 
substrate (Zymed, San Francisco, CA). The 
reaction was stopped with 2N H2SO4, and the 
plate was read on a SpectraMax plate reader 
(Molecular Devices, Sunnyvale, CA). All data 
were evaluated against a standard curve, using 
human IgA (Sigma, St. Louis, MO). 
RF ELISA. RF in the subjects' serum was 
measured with an ELISA kit according to the 
Table 1. Simple classification of ARD severity. 
Disease severity Criteria used Ordinal value 
None No reported lung pathology 0 
Limited Unilateral radiograph abnormality 1 
Moderate Bilateral abnormality, minimal functional deficit 2 
Severe Bilateral abnormality, severe or progressive functional deficit 3 
Table 2. Asbestos exposure scores determined from screening data. 
Asbestos exposure Criteria used Ordinal value 
None No reported occupational or environmental 0 
asbestos exposure 
Minimal < 5 years, only occupational or environmental 1 
Low < 5 years, both occupational and environmental 2 
Moderate > 5 years, only occupational or environmental 3 
High > 5 years, both occupational and environmental 4 
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manufacturer's protocol (INOVA Diagnostics). 
The plates were read on the SpectraMax plate 
reader. Optical density (OD) values were com? 
pared with known controls provided with the 
kit and rated as negative or positive (marginal, 
moderate, or high). 
ENA array. Analyses of antibodies to five 
extractable nuclear proteins commonly seen 
in SAID (Sm, RNP, SS-A, SS-B, and Scl-70) 
were performed using an addressable bead 
array kit (QuantaPlex ENA-5; INOVA 
Diagnostics) according to the manufacturer's 
instructions, on a Luminex multiplex system 
(MiraiBio, Alameda, CA). The values were 
compared by using MasterPlex software 
(MiraiBio) to negative and graduated positive 
control reagents provided with the kit, and 
determined to be low, moderate, or high posi? 
tive, or negative. 
Statistics. In this study we included analy? 
sis of several different types of data, including 
percentages/frequencies (e.g., ANA frequen? 
cies), ordinal (e.g., disease status assessed on a 
4-point scale), and scale (e.g., mg/mL IgA) 
data. Consequently, we used the following sta? 
tistical methods: a) differences in percentages 
were tested using raw frequencies with Fisher's 
exact test; b) contingency tables with 4- and 
5-point ordinal level frequency comparisons 
were made via the chi-square test; and c) inde? 
pendent sample Mests were used for scale 
measures. In the Libby samples, comparisons 
(correlations) between ANA levels and disease 
and exposure rankings were made using the 
nonparametric Spearman rank correlation. In 
all analyses we used two-tailed, unpaired 
analyses, and reported 0.05 type I error levels. 
Data reported in the text are mean ? SEM. 
Results 
Frequency and fluorescence intensity of positive 
ANAs. The 50 serum samples in each set were 
tested by IIF and were determined to be posi? 
tive or negative for ANA based on known con? 
trols. Figure IA shows that the relative 
frequency of positive ANAs was 28.6% higher 
in the Libby sample set than in the Missoula 
set {p = 0.006). Because low-titer positive 
ANAs are fairly common in normal popula? 
tions, the ANA slides were scored for fluores? 
cence intensity. The scored mean.fluorescence 
intensity of ptositive ANAs, rated on a scale of 
1-4 against known controls, was higher in the 
Libby sample set (mean = 2.34 ? 0.153) com? 
pared with those from Missoula (1.76 ? 0.194; 
p = 0.02), and the distribution of subjects 
receiving the various scores was shown to be 
significantly different between the sample sets 
(p = 0.004; Figure 1B). The scored fluores? 
cence intensity is not a direct quantification of 
autoantibodies but generally suggests a higher 
titer. Therefore, the positive samples were sub? 
sequendy titered to 1:1,280 and further ana? 
lyzed for ANA. In both groups, the ANA 
scores and titers were highly correlated, sug? 
gesting that the scoring provides a close estima? 
tion of titer (Missoula: correlation coefficient = 
0.502, p < 0.001; Libby: correlation coefficient 
= 0.828, p < 0.001; Table 3). We found that 
the distribution of titers for samples in the two 
sample sets were significantly different 
(p = 0.036; data not shown). The percentage of 
subjects having a positive ANA at a titer > 320 
is shown in Figure 1C, again showing a signifi? 
cant difference between the two sample sets. 
IgA levels and RF. Because other studies 
of asbestos-exposed populations have shown 
differences in serum IgA compared with 
unexposed subjects, serum IgA levels were 
analyzed by ELISA in our sample sets. The 
Libby samples showed significantly higher 
levels of serum IgA than the Missoula samples 
(Figure 2). Although both sample sets had 
mean IgA concentrations within normal 
ranges (- 0.9-4.5 mg/mL), the Libby mean 
was at the high end of the range (4.2 mg/mL). 
The ANA tests were subsequendy modified to 
detect IgA rather than IgG, and all of the 
ANA tests were negative in both sample sets, 
indicating that the autoantibodies were most 
likely primarily IgG and not IgA (data not 
shown). 
RF consists of IgM or IgG antibodies 
directed against the constant domain of 
immunoglobulin. These autoantibodies can 
lead to immune complex deposition in tissues 
Missoula Libby 0 12 3 4 
ANA fluorescence score 
Missoula Libby 
Figure 1. Comparison of ANA in Libby samples with the Missoula samples. (A) Positive and negative tests 
determined based on known controls provided with the kits (*p = 0.004, Fisher's exact test; n = 50). (B) ANA 
fluorescence intensity score based on known controls (p = 0.004, Pearson chi-squaretest). (Q Percentage 
in each group with a titer > 320 (**p < 0.01, Fisher's exact test; n = 50). ANA tests were performed as 
described in "Materials and Methods." Groups were screened at a serum dilution of 1:40 and read by two 
readers; positive tests were then titered to 1:1,280. 
and are associated with a variety of infectious 
and inflammatory disorders such as RA. The 
samples were evaluated for IgM RF by ELISA, 
and there were no differences in either the 
mean OD calculated for each sample set or the 
frequency of positive tests for RF (Figure 3). 
Staining patterns on ANAs. To determine 
the specific targets for the IgG autoantibodies, 
we analyzed the patterns visible on the ANA 
tests. In the Missoula samples, a nuclear speck- 
led staining pattern was most common, as 
expected in a normal population (speckled, 
14%; homogeneous, 12%; nucleolar, 10%). 
Other staining patterns were relatively rare, as 
expected. However, in the Libby samples, 
homogeneous (indicative of antibodies to chro- 
matin) and nucleolar staining patterns were 
more prevalent, although the differences were 
not statistically significant (speckled, 18%; 
homogeneous, 22%; nucleolar, 18%). We 
tested for specific antibodies related to these 
IIF patterns using an ELISA for chromatin and 
Table 3. Correlation coefficients (CC) with immune 
parameters in the Libby cohort. 
*Correlation is significant at the 0.05 level (two-tailed 
Spearman's rho test). **Correlation is significant atthe 
0.01 level (two-tailed Spearman's rho test). 
0.00 
Missoula Libby 
Figure 2. Serum IgA levels were significantly 
higher in the Libby group. Serum IgA was meas? 
ured by ELISA using anti-human IgA capture and 
detection (HRP-conjugated) antibodies from 
Southern Biotech and Caltag, respectively. The 
samples were tested in duplicate, developed using 
TMB, and read on a SpectraMax plate reader. 00 
was compared with a standard curve (human IgA, 
Sigma) to calculate values (mg/mL, n = 50). 
*p = 0.002, two-tailed f-test 
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an IIF assay for anti-dsDNA (Crithidia luciliae 
test). The results indicated that although 22% 
of the Libby group had homogeneous staining 
patterns, less than half of those were positive 
for either chromatin or dsDNA (Figure 4). 
This suggests that either individual histones 
not available for binding in chromatin prepara- 
tions (i.e., H3, H4) or other components of 
chromatin may be the targets being recognized 
by the autoantibodies in these individuals. 
Serum antibodies to ENAs. To further 
explore possible targets for the autoantibodies, 
we used a Lumine multiplex analyzer with an 
addressable laser bead immunoassay to detect 
antibodies to five ENAs. Twelve of the Libby 
samples (24%) had positive ENA tests, with 
most of the positive samples having more than 
one of the antibody specificities. The Missoula 
sample set had only two samples (4%) with 
positive ENA tests. These differences were sta? 
tistically significant by Fisher's exact test 
(p = 0.004; data not shown). Figure 5 shows 
the distribution of positive tests in each group 
for all five antigens tested. 
Immune parameter correlations. Table 3 
shows statistical correlations among tested 
immune parameters within the Libby sample 
set, using Spearman's rho nonparametric test. 
As might be expected based on the epidemiol? 
ogy of autoimmune diseases, the age of the 
individual was positively correlated with the 
ANA titer, ANA score, and RF. RF was also 
correlated with ANA titer. IgA levels were not 
correlated with any other parameter, so the 
physiologic significance of the elevation seen 
in the Libby samples remains unclear. 
Correlation of assay results with extent of 
exposure and ARD. In addition to the correla? 
tions shown above, the immune parameters 
were analyzed against the scores of exposure 
levels and ARD status, as described in 
"Materials and Methods." Table 4 shows that 
there were significant positive associations 
between ANA titers and both asbestos expo? 
sure and disease status. Because a central 
hypothesis relating to asbestos toxicology is 
that asbestos exposure is positively associated 
: - . r. 'J x.'} .!?> v.vSf-;::.v ' i\- *?'-*?>?-::* 
Missoula Libby 
Figure 3. Evaluation for IgM RF by ELISA. Neither 
the percent positive (based on kit positive and neg? 
ative controls) nor the mean 0D calculated for 
each group was statistically significant (Fisher's 
exact test and f-test, respectively). 
with ARD, we tested that correlation using 
our scoring system. The correlation between 
disease and exposure was 0.239, consistent 
with the hypothesis (Table 4). 
The analysis for asbestos exposure was per? 
formed using the graded system described in 
Table 2, but in looking at the data, it was 
apparent that the largest effect on ANA titer 
was seen in terms of length of exposure rather 
than the source (occupational or environ? 
mental). Figure 6A shows the mean ANA titers 
for the Libby samples when subgrouped by 
duration of exposure and demonstrates that the 
titers were significantly higher for those sub? 
jects exposed to asbestos for > 5 years. When 
samples were separated according to whether 
the subject was exposed environmentally or 
occupationally, no significant difference in 
mean ANA titer was observed in those two 
groups (Figure 6B). This suggests that the 
duration of exposure had a greater impact on 
autoimmune responses than the source of 
exposure. It should be noted that none of the 
subjects reported solely occupational exposures; 
all also had environmental exposures as well. 
Discussion 
By demonstrating an association between 
asbestos exposure and measures of auto? 
immune responses, this study supports and 
augments other existing evidence that, like sil? 
ica, asbestos is an agent of systemic auto? 
immunity. Asbestos-contaminated vermiculite 
from Libby has been shipped and processed in 
many sites in the United States, and this mate? 
rial is still used in many applications. It there? 
fore remains a significant health risk to 
humans both occupationally and environ? 
mentally, and an awareness of an association 
with autoimmunity could impact necessary 
monitoring, testing, and treatment regimens 
for exposed individuals or populations. 
In addition, this study establishes the 
Libby population as an excellent cohort for 
further study of the immunologic aspects of 
o1 
Homogeneous dsDNA Chromatin 
Figure 4. Assessment of autoantibodies targeted to 
dsDNA or chromatin in subjects with homogeneous 
ANA patterns. See "Materials and Methods" for 
details. Tests for antibodies to individual histones 
were not performed, but that target is indicated for 
those homogeneous patterns without antibodies to 
dsDNA or chromatin itself. 
asbestos toxicology. It is a unique population 
with both occupational and environmental 
exposures, excellent ongoing monitoring and 
demographic data, enthusiasm for participa? 
tion in these studies, and sufficient numbers 
of exposed individuals to develop sample sets 
with adequate power for statistical analyses of 
many parameters. The objective of this study 
was to compare the frequency of serum auto? 
antibodies in two matched populations, one 
of them having significant asbestos exposure. 
It was designed as an initial study in order to 
explore the feasibility and justification for a 
more extensive study of autoimmunity in the 
Libby population. 
Previous studies have measured several 
immune parameters in populations exposed, 
primarily occupationally, to asbestos. Nigam 
et al. (1993) demonstrated increased IgG and 
IgA and positive ANAs in asbestos-exposed 
individuals compared with controls, even in 
the absence of apparent ARD. This finding 
suggested that immune alterations may pre- 
cede the onset of ARD. A high frequency of 
positive ANAs was also found in a Japanese 
group of asbestos plant workers (Tamura et al. 
1993). Interestingly, a 3-year follow-up study 
of the Japanese group showed significant cor? 
relation of positive ANAs with progression of 
the disease, leading to additional diagnoses of 
asbestosis in a previously healthy group 
(Tamura et al. 1996); this suggests that auto? 
immunity may play a role in ARD. Because 
that important observation needs to be con- 
firmed, the present study also forms the basis 
for a similar progressive study of the Libby 
population to explore the temporal relation? 
ship between autoimmunity and ARD. If 
autoimmune responses play a role in the pro? 
gression of ARD, this would become an 
important target for therapeutic strategies. 
A higher frequency of positive ANA was 
seen in the Libby sample set compared with 
the samples from Missoula, even though the 
RNP Scl-70 Sm SS-A SS-B 
Target antigens 
Figure 5. Increased frequency of positive ENA tests 
in Libby samples compared with Missoula samples. 
Tests were performed as described in "Materials 
and Methods." Numbers above the bars are p-values 
indicating the statistical difference between Libby 
samples and Missoula samples (determined by 
Fisher's exact test; n = 50). 
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Missoula ANA positive frequency was fairly 
high (40%). This high "normal" frequency 
may be due to the age of the population, the 
low dilution used (1:40) for the screening, or 
other unidentified population considerations. 
Nevertheless, the Libby sample set showed a 
28.6% increase above that seen for the 
Missoula samples. In addition, the mean fluo? 
rescence intensity of the ANAs, as well as the 
titers, were higher in the Libby samples com? 
pared with the Missoula samples. Although 
higher titers of autoantibodies are not neces? 
sarily correlated with an autoimmune disease 
process, in some cases increased titers can indi? 
cate an exacerbation, relapse, or stage of an 
autoimmune process. 
Other immune parameters showed differ? 
ences in the Libby group as well, including 
increases in serum IgA. Serum IgA is generally 
found at relatively low levels, but increased 
levels are associated with some chronic 
inflammatory disorders, such as occupational 
lung disease, psoriatic arthritis, Crohn's dis? 
ease, and ankylosing spondylitis (Hoffman 
et al. 2003; Lindqvist et al. 2002; Zhestkov 
2000). The significance of increased serum 
IgA levels in the Libby samples is not clear, 
but it is consistent with other studies of 
asbestos-exposed subjects (Nigam et al. 1993; 
Zerva et al. 1989). We demonstrated that the 
autoantibodies detected by ANA were not of 
the IgA isotype, so it is possible that the IgA 
antibodies are simply elicited by nonspecific 
chronic inflammatory processes in these indi? 
viduals. This possibility is supported by the 
Table 4. Correlation coefficients (CC) between 
immune parameters and scores both of asbestos 
exposure and of asbestos-related disease. 
*Correlation is significant at 0.05 (two-tailed Spearman's 
rho test). **Correlation is significant at 0.01 (two-tailed 
Spearman's rho test). 
lack of correlation between IgA titers and 
either ANA or asbestos exposure; however, a 
correlation between IgA titers and disease sta? 
tus was also lacking in our analysis. 
We found no difference between the two 
sample sets in terms of frequency of positive 
tests for RF, and in general the positive sam? 
ples in both groups were rated marginal to 
moderate when compared with known con? 
trols (data not shown). There was also no cor? 
relation between RF and asbestos exposure. 
These results suggest that asbestos exposure is 
not associated with increases in RF, especially 
because previous studies of asbestos-exposed 
populations have not consistently reported 
elevated RF. Interestingly, we found a posi? 
tive association of RF with lung disease status. 
This may suggest that the presence of RF is 
more dependent on the chronic inflammation 
resulting from the ARD than on asbestos 
exposure itself. Alternatively, because there 
were positive correlations between RF and 
both ANA titer and ARD, the threshold of 
asbestos exposure impacting development of 
RF may simply be too low to be detected 
using the simplified exposure scale (Table 2). 
Therefore, the pathophysiologic significance 
of these results remains to be determined with 
further study. Although assaying RF is a good 
screening tool, it is not specific for RA. An 
alternative test would be an assay for cyclic 
citrullinated peptide (CCP), a more specific 
epitope characteristic of autoantibodies in RA 
(Bombardieri et al. 2004; Saraux et al. 2003) 
because CCP can antedate clinical RA. 
The Libby sample set had a significantly 
higher number of total positive ENA subjects 
(24% vs. 4% in the Missoula group). ENAs are 
defined target antigens in a variety of auto? 
immune diseases, including systemic lupus, 
mixed connective tissue disease, systemic sclero- 
sis, and polymyositis (Pahor et al. 1998). In 
HEp-2 cells, most of these antibodies produce a 
speckled or atypical speckled pattern. 
Therefore, our combined data suggest that the 
major responses in asbestos-exposed individuals 
include antibody development to targets such 
as chromatin components (i.e., histone) or 
nucleolar components (fibrillarin, DNA topo? 
isomerase I), which give the homogeneous 
and nucleolar patterns, and several ENAs that 
give the speckled pattern. There are auto? 
antibodies?other than those detected by the 
assay used here?that could give the speckled 
patterns seen in both populations. Analysis of 
a more comprehensive array of autoantigens 
may provide more insight into the spectrum 
of autoantibodies related to asbestos exposure. 
The presence of autoantibodies does not 
necessarily suggest a disease process. However, 
to begin to explore a possible role of these 
antibodies in the health of the population in 
Libby, data regarding the extent of ARD 
severity were gathered as described in 
"Materials and Methods." Extent of exposure 
included both duration and site of exposure 
(work vs. recreational/home). The data 
showed that individuals with longer exposures, 
and especially if exposed both at work and at 
home, had higher ANA titer than those with 
shorter exposures (< 5 years). Disease status 
considered the extent of fibrosis or plaquing, 
as well as functional deficits. Again, the data 
showed increasing ANA titer with increasing 
disease severity. The stronger correlation 
between ANA titer and disease than between 
ANA titer and exposure may be due to impre- 
cise scoring systems. Exposure and ARD are 
assumed to be correlated (Peipins et al. 2003), 
even though this correlation was only at the 
90th percentile using our scoring systems. 
Therefore, these data do not exclude the possi? 
bility that the correlation of ANA titer with 
exposure may be secondary to the chronic 
inflammation and tissue damage of the associ? 
ated ARD. It is interesting to note, however, 
that of those 494 participants from the Libby 
Tremolite Asbestos Registry cohort with sus- 
pected SAID, 171 (35%) have had pleural 
and/or interstitial abnormalities indicated on 
chest radiographs and confirmed by two 
B-readers (Larson T, personal communica? 
tion). These cross-sectional findings suggest 
that the proportion of radiographic abnormal? 
ities among participants with suspected SAID 
(35%) was almost double the proportion of 
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Figure 6. ANA titer (mean ? SD) for subsets of the Libby samples based on length of asbestos exposure (A) 
or source of exposure (B) as environmental (household contact, used in garden, etc.) or occupational 
(worked in vermiculite mine or processing). 
*p < 0.01 by two-tailed f-test. 
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radiographic abnormalities among the entire 
Libby cohort (> 18%) (Peipins et al. 2003). 
Further study is required to determine if, and 
how, autoimmune responses are related to 
ARD and whether autoimmunity influences 
ARD progression. 
Conclusion 
We have established that there are significant 
differences in frequency and titer of positive 
ANA tests, frequency of positive ENA tests, 
and higher levels of serum IgA when an 
asbestos-exposed Libby cohort was compared 
with one from Missoula with no reported 
asbestos exposures. We have also shown sig? 
nificant associations between asbestos expo? 
sure and ANA titer. These data support the 
hypothesis that asbestos exposure is associ? 
ated with autoimmune responses. The corre? 
lations of ARD with ANA titer, ANA score, 
and RF suggest the possibility that auto? 
immunity could play a role in the progres? 
sion of ARD. This study provides the 
foundation and justification for a larger and 
more extensive study, planned to explore 
these associations much more rigorously. 
These studies will increase our understand? 
ing ofthe immune components of ARD and 
could lead to improved interventions as an 
ultimate goal of the discovery of interrelated 
pathologies. 
References 
ATSDR. 2002. Prelinimary Findings of Libby, Montana, Asbestos 
Medical Testing (Combined Testing, 2000 and 2001). Atlanta, 
GA.Agency for Toxic Substances and Disease Registry. 
Bombardieri M, Alessandri C, Labbadia G, lannuccelli C, 
Carlucci F, Riccieri V, et al. 2004. Role of anti-cyclic citrulli- 
nated peptide antibodies in discriminating patients with 
rheumatoid arthritis from patients with chronic hepatitis C 
infection-associated polyarticular involvement. Arthritis 
ResTher6:R137-R141. 
Fritzler MJ. 1994. Drugs recently associated with lupus yn- 
dromes. Lupus 3:455-459. 
Hamilton RF, lyer LL, Holian A. 1996. Asbestos induces apo- 
ptosis in human alveolar macrophages. Am J Physiol 
2711813-L819. 
Hoffman IE, Demetter P, Peeters M, De Vos M, Mielants H, 
Veys EM, et al. 2003. Anti-Saccharomyces cerevisiae IgA 
antibodies are raised in ankylosing spondylitis and undiffer? 
entiated spondyloarthropathy. Ann Rheum Dis 62:455-459. 
Holian A, Uthman M0, Goltsova T, Brown SD, Hamilton RF. 1997. 
Asbestos and silica-induced changes in human alveolar 
macrophage phenotype. Environ Health Perspect 
105:1139-1142. 
Jacobson DL, Gange SJ, Rose NR, Graham NM. 1997. 
Epidemiology and estimated population burden of selected 
autoimmune diseases in the United States. Clin Immunol 
Immunopathol 84:223-243. 
Koeger AC, Lang T, Alcaix D, Milleron B, Rozenberg S, Chaibi P, 
et al. 1995. Silica-associated connective tissue disease. A 
study of 24 cases. Medicine (Baltimore) 74:221-237. 
Lange A. 1980. An epidemiological survey of immunological 
abnormalities in asbestos workers. II. Serum immuno- 
globulin levels. Environ Res 22:176-183. 
Lindqvist U, Rudsander A, Bostrom A, Nilsson B, Michaelsson G.
2002. IgA antibodies to gliadin and coeliac disease in psori- 
atic arthritis. Rheumatology (Oxford) 41:31-37. 
Nigam SK, Suthar AM, Patel MM, Karnik AB, Dave SK, 
Kashyap SK, et al. 1993. Humoral immunological profile of 
workers exposed to asbestos in asbestos mines. Indian J 
Med Res 98:274-277. 
Pahor A, Krajnc I, Gorenjak M, Holc 1.1998. The clinical signifi? 
cance of antinuclear antibodies in connective tissue 
disease. Wien Klin Wochenschr 110:338-341. 
Parks CG, Conrad K, Cooper GS. 1999. Occupational exposure 
to crystalline silica and autoimmune disease. Environ 
Health Perspect 107:793-802. 
Peipins LA, Lewin M, Campolucci S,Lybarger JA, Miller A, 
Middleton D, et al. 2003. Radiographic abnormalities and 
exposure to asbestos-contaminated vermiculite in the 
community of Libby, Montana, USA. Environ Health 
Perspect 111:1753-1759. 
Perkins RC, Scheule RK, Hamilton R, Gomes G, Freidman G, 
Holian A. 1993. Human alveolar macrophage cytokine 
release in response to in vitro and in vivo asbestos expo? 
sure. Exp Lung Res 19:55?65. 
Powell JJ, Van de Water J, Gershwin ME. 1999. Evidence for the 
role of environmental agents in the initiation rprogression 
of autoimmune conditions. Environ Health Perspect 
107(suppl 5):667-672. 
Saraux A, Berthelot JM, Devauchelle V, Bendaoud B, Chales G, 
Le Henaff C, et al. 2003. Value of antibodies tocitrulline- 
containing peptides for diagnosing early rheumatoid 
arthritis. J Rheumatol 30:2535-2539. 
Steenland K, Goldsmith DF. 1995. Silica exposure and auto? 
immune diseases. Am J Ind Med 28:603-608. 
Tamura M, Liang D, Tokuyama T, Yoneda T, Kasuga H, Narita N, 
et al. 1993. Study on the relationship between appearance 
of autoantibodies and chest X-ray findings of asbestos 
plant employees [in Japanese]. Sangyo Igaku 35:406-412. 
Tamura M, Tokuyama T, Kasuga H, Yoneda T, Miyazaki R, 
Narita N. 1996. Study on correlation between chest X-P 
course findings and change in antinuclear antibody in 
asbestos plant employees [in Japanese]. Sangyo Eiseigaku 
Zasshi 38:138-141. 
U.S. Census Bureau. 2004, State & County QuickFacts. Available: 
http://quickfacts.census.gov [accessed 14 September 2004]. 
Zerva LV, Constantopoulos SH, Moutsopoulos HM. 1989. 
Humoral immunity alterations after environmental asbestos 
exposure. Respiration 55:237-241. 
Zhestkov AV. 2000. Immunological hanges in dust-induced 
lung diseases [in Russtan]. Gig Sanit Nov-Dec(6):30-33. 
30 volume 1131 number 11 January 2005 ? Environmental Health Perspectives 
This content downloaded from 150.131.192.151 on Tue, 17 Sep 2013 15:53:33 PM
All use subject to JSTOR Terms and Conditions
